Archives

Cardinal Health (NYSE: CAH) today announced that its board of directors has elected J. Michael Losh as an independent director effective December 5. Losh will serve as the chairman of the Audit...

Oncologists are growing more confident in their ability to meet the requirements of the Medicare Access & CHIP Reauthorization Act (MACRA), according to new research from Cardinal Health Specialty...

DUBLIN, Ohio, November 28, 2018 — Cordis, a Cardinal Health company (NYSE: CAH), today announced that the U.S. Food and Drug Administration (FDA) has approved its INCRAFT® AAA Stent Graft...

Cardinal Health inventory management solutions (also known as WaveMark™) has introduced a supply chain automation solution designed for the unique challenges hospitals face in operating rooms...

At the 2018 American Society of Health System Pharmacists (ASHP) Midyear Clinical Meeting, Cardinal Health will highlight a comprehensive approach that addresses the top concern of hospital and...

Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2019 revenues of $35.2 billion, an increase of 8 percent. The company also reported growth in GAAP operating earnings of 211...

Cordis, a Cardinal Health company, today announced the U.S. launch of MYNX CONTROL™ Vascular Closure Device (VCD). MYNX CONTROL™ VCD integrates active...

Cardinal Health (NYSE: CAH) today announced that Victor Crawford will be joining the company as its next CEO of the Pharmaceutical Segment. Victor's most recent role was Chief Operating Officer,...

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2019 on November 8 prior to the opening of trading on the New York Stock Exchange. The company will...

The inaugural Women Pharmacist Day will be commemorated on Oct. 12, 2018, in conjunction with National Pharmacist Month, to recognize the important contributions women pharmacists make, every day,...